Supremacie - 14783-093-94 - (Ensulizole, Homosalate, Octinoxate, Oxybenzone, and Titanium Dioxide)

Alphabetical Index


Drug Information of Supremacie

Product NDC: 14783-093
Proprietary Name: Supremacie
Non Proprietary Name: Ensulizole, Homosalate, Octinoxate, Oxybenzone, and Titanium Dioxide
Active Ingredient(s): .00075; .001; .00375; .00225; .000585    g/5mL; g/5mL; g/5mL; g/5mL; g/5mL & nbsp;   Ensulizole, Homosalate, Octinoxate, Oxybenzone, and Titanium Dioxide
Administration Route(s): TOPICAL
Dosage Form(s): CREAM
Coding System: National Drug Codes(NDC)

Labeler Information of Supremacie

Product NDC: 14783-093
Labeler Name: Ventura International LTD
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20100104

Package Information of Supremacie

Package NDC: 14783-093-94
Package Description: 1 TUBE in 1 BOX (14783-093-94) > 5 mL in 1 TUBE (14783-093-93)

NDC Information of Supremacie

NDC Code 14783-093-94
Proprietary Name Supremacie
Package Description 1 TUBE in 1 BOX (14783-093-94) > 5 mL in 1 TUBE (14783-093-93)
Product NDC 14783-093
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Ensulizole, Homosalate, Octinoxate, Oxybenzone, and Titanium Dioxide
Dosage Form Name CREAM
Route Name TOPICAL
Start Marketing Date 20100104
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Ventura International LTD
Substance Name ENSULIZOLE; HOMOSALATE; OCTINOXATE; OXYBENZONE; TITANIUM DIOXIDE
Strength Number .00075; .001; .00375; .00225; .000585
Strength Unit g/5mL; g/5mL; g/5mL; g/5mL; g/5mL
Pharmaceutical Classes

Complete Information of Supremacie


General Information